Search
Advanced search

Company search

Company/VAT no/Free text Country/City/Municipality

TURNOVER (x1000 NOK)

NET PROFIT (x1000 NOK)

Share

Cytiva BioProcess R&D AB

Closing information (x1000 NOK)

Closing information 2023/12 2022/12 2021/12
Turnover 12,954,256 More Arrow 16,091,605 Less Arrow 14,419,915
Financial expenses 0 More Arrow 10,919 More Arrow 12,874
Earnings before taxes 6,100,224 More Arrow 9,366,376 Less Arrow 7,689,012
EBITDA 12,424,053 More Arrow 15,593,914 Less Arrow 14,115,989
Total assets 37,427,767 Less Arrow 33,495,515 Less Arrow 25,897,047
Current assets 15,129,988 Less Arrow 12,459,577 Less Arrow 240,634
Current liabilities 14,425,652 More Arrow 21,641,178 Less Arrow 13,111,310
Equity capital 23,002,115 Less Arrow 10,910,163 Less Arrow 10,401,205
- share capital 101 Less Arrow 95 More Arrow 98
Employees (average) 0 Equal arrow 0 Equal arrow 0

Financial ratios

Fiscal year 2023/12 2022/12 2021/12
Solvency 61.5% Less Arrow 32.6% More Arrow 40.2%
Turnover per employee
Profit as a percentage of turnover 47.1% More Arrow 58.2% Less Arrow 53.3%
Return on assets (ROA) 16.3% More Arrow 28.0% More Arrow 29.7%
Current ratio 104.9% Less Arrow 57.6% Less Arrow 1.8%
Return on equity (ROE) 26.5% More Arrow 85.9% Less Arrow 73.9%
Change turnover -4,279,160 More Arrow 2,105,069 More Arrow 4,708,625
Change turnover % -25% More Arrow 15% More Arrow 48%
Chg. No. of employees 0 Equal arrow 0 Equal arrow 0
Chg. No. of employees %

Total value of public sale

Fiscal year 2023/12 2022/12 2021/12
Total value of public sale 0 Equal arrow 0 Equal arrow 0

Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank

The closing information is gathered directly from the companies or from Creditsafe.